Multivariate NTCP Model of Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Sep 10

PMID 34504792

Citations 6

Authors

Guanzhu Shen

Yinglin Peng

Jian Li

Haijun Wu

Guangshun Zhang

Chong Zhao

Xiaowu Deng

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the incidence of hypothyroidism in patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy (IMRT), analyze its correlation with multiple influencing factors such as thyroid exposure dose, thyroid volume, and gender, and construct a multivariate-based normal tissue complication probability (NTCP) model for the occurrence of hypothyroidism after IMRT.

Materials And Methods: The thyroid hormone levels of patients at different points in time before and after radiotherapy were tested, and statistics on the incidence of hypothyroidism after treatment were obtained. The dose-volume data of patients' thyroids were converted into EQD2 equivalent dose values. The correlation between hypothyroidism after radiotherapy and thyroid exposure dose, thyroid volume, gender, and other factors was analyzed, and an NTCP model was constructed.

Results: A total of 69 patients with nasopharyngeal carcinoma were enrolled in this study. Twelve months after radiotherapy, a total of 24 patients (34.8%) developed hypothyroidism. Univariate analysis and multivariate analysis revealed that the average thyroid dose and thyroid volume are the most important factors affecting hypothyroidism after radiotherapy. The NTCP model constructed based on the average dose and thyroid volume has a good degree of fit.

Conclusion: The volume and average dose of the thyroid gland are the key factors affecting the occurrence of hypothyroidism in patients with nasopharyngeal carcinoma after radiotherapy. The NTCP model constructed based on multivariate construction suggests that reducing the average dose of the thyroid to the greatest extent is an effective way to protect thyroid functions.

Citing Articles

Preliminary study on the correlation between thyroid magnetic resonance parameters and radiation dose after radiotherapy for nasopharyngeal carcinoma.

Lu K, Zhou C, Ren J, Ni J, Yang W, Wang Y Front Public Health. 2025; 12():1526147.

PMID: 39850855 PMC: 11756455. DOI: 10.3389/fpubh.2024.1526147.

Thyroid avoidance in treatment planning for breast cancer patients irradiated to the supraclavicular nodes.

Clivio A, Zwahlen D, Koch S, Negreanu C, Barletta E, Haerle H Strahlenther Onkol. 2024; .

PMID: 39585411 DOI: 10.1007/s00066-024-02321-8.

A machine learning approach for predicting radiation-induced hypothyroidism in patients with nasopharyngeal carcinoma undergoing tomotherapy.

Quan K, Lin W, Hong J, Lin Y, Chen K, Chen J Sci Rep. 2024; 14(1):8436.

PMID: 38600141 PMC: 11006930. DOI: 10.1038/s41598-024-59249-3.

A multivariable normal tissue complication probability model for predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma patients in the modern radiotherapy era.

Wongwattananard S, Prayongrat A, Srimaneekarn N, Hayter A, Sophonphan J, Kiatsupaibul S J Radiat Res. 2023; 65(1):119-126.

PMID: 37996086 PMC: 10803165. DOI: 10.1093/jrr/rrad091.

Improved prediction of radiation-induced hypothyroidism in nasopharyngeal carcinoma using pre-treatment CT radiomics.

Ritlumlert N, Wongwattananard S, Prayongrat A, Oonsiri S, Kitpanit S, Kannarunimit D Sci Rep. 2023; 13(1):17437.

PMID: 37838730 PMC: 10576799. DOI: 10.1038/s41598-023-44439-2.

References

Bakhshandeh M, Hashemi B, Mahdavi S, Nikoofar A, Vasheghani M, Kazemnejad A . Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapy. Int J Radiat Oncol Biol Phys. 2012; 85(2):514-21. DOI: 10.1016/j.ijrobp.2012.03.034. View

Lo Galbo A, de Bree R, Kuik D, Lips P, Mary B, Von Blomberg E . The prevalence of hypothyroidism after treatment for laryngeal and hypopharyngeal carcinomas: are autoantibodies of influence?. Acta Otolaryngol. 2007; 127(3):312-7. DOI: 10.1080/00016480600818096. View

Siala W, Mnejja W, Abid M, Ghorbel A, Frikha M, Daoud J . Thyroid toxicity after radiotherapy of nasopharyngeal carcinoma. Ann Endocrinol (Paris). 2010; 72(1):19-23. DOI: 10.1016/j.ando.2010.06.005. View

Luo R, Wu V, He B, Gao X, Xu Z, Wang D . Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients. BMC Cancer. 2018; 18(1):575. PMC: 5960211. DOI: 10.1186/s12885-018-4348-z. View

Haciislamoglu E, Canyilmaz E, Gedik S, Aynaci O, Serdar L, Yoney A . Effect of dose constraint on the thyroid gland during locoregional intensity-modulated radiotherapy in breast cancer patients. J Appl Clin Med Phys. 2019; 20(7):135-141. PMC: 6612689. DOI: 10.1002/acm2.12668. View

Feehs R, McGuirt W, Bond M, Strickland H, Craven T, Hiltbrand J . Irradiation. A significant risk factor for carotid atherosclerosis. Arch Otolaryngol Head Neck Surg. 1991; 117(10):1135-7. DOI: 10.1001/archotol.1991.01870220083014. View

Ulger S, Ulger Z, Yildiz F, Ozyar E . Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma. Med Oncol. 2007; 24(1):91-4. DOI: 10.1007/BF02685908. View

Peng L, Mao Y, Huang C, Guo R, Ma J, Wen W . A New Model for Predicting Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma. Front Oncol. 2020; 10:551255. PMC: 7546200. DOI: 10.3389/fonc.2020.551255. View

Zhou L, Chen J, Shen W, Chen Z, Huang S, Tao C . Thyroid V is a risk factor for hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: a retrospective study. Radiat Oncol. 2020; 15(1):68. PMC: 7087364. DOI: 10.1186/s13014-020-01490-x. View

10.

Huang S, Wang X, Hu C, Ying H . Hypothalamic-pituitary-thyroid dysfunction induced by intensity-modulated radiotherapy (IMRT) for adult patients with nasopharyngeal carcinoma. Med Oncol. 2013; 30(4):710. DOI: 10.1007/s12032-013-0710-9. View

11.

Peng Y, Chen L, Shen G, Li Y, Yao J, Xiao W . Interobserver variations in the delineation of target volumes and organs at risk and their impact on dose distribution in intensity-modulated radiation therapy for nasopharyngeal carcinoma. Oral Oncol. 2018; 82:1-7. DOI: 10.1016/j.oraloncology.2018.04.025. View

12.

Zhang S, Park K, Oh S, Cho H, Cho H, Park J . NF-kappaB decoy potentiates the effects of radiation on vascular smooth muscle cells by enhancing apoptosis. Exp Mol Med. 2005; 37(1):18-26. DOI: 10.1038/emm.2005.3. View

13.

Cannon C . Hypothyroidism in head and neck cancer patients: experimental and clinical observations. Laryngoscope. 1994; 104(11 Pt 2 Suppl 66):1-21. DOI: 10.1288/00005537-199411001-00001. View

14.

Akgun Z, Atasoy B, Ozen Z, Yavuz D, Gulluoglu B, Sengoz M . V30 as a predictor for radiation-induced hypothyroidism: a dosimetric analysis in patients who received radiotherapy to the neck. Radiat Oncol. 2014; 9:104. PMC: 4029831. DOI: 10.1186/1748-717X-9-104. View

15.

Vogelius I, Bentzen S, Maraldo M, Petersen P, Specht L . Risk factors for radiation-induced hypothyroidism: a literature-based meta-analysis. Cancer. 2011; 117(23):5250-60. DOI: 10.1002/cncr.26186. View

16.

Bhandare N, Kennedy L, Malyapa R, Morris C, Mendenhall W . Primary and central hypothyroidism after radiotherapy for head-and-neck tumors. Int J Radiat Oncol Biol Phys. 2007; 68(4):1131-9. DOI: 10.1016/j.ijrobp.2007.01.029. View

17.

Xu Y, Shao Z, Tang T, Liu G, Yao Y, Wang J . A dosimetric study on radiation-induced hypothyroidism following intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma. Oncol Lett. 2018; 16(5):6126-6132. PMC: 6202536. DOI: 10.3892/ol.2018.9332. View

18.

Bakhshandeh M, Hashemi B, Mahdavi S, Nikoofar A, Edraki H, Kazemnejad A . Evaluation of thyroid disorders during head-and-neck radiotherapy by using functional analysis and ultrasonography. Int J Radiat Oncol Biol Phys. 2011; 83(1):198-203. DOI: 10.1016/j.ijrobp.2011.05.064. View

19.

Sachdev S, Refaat T, Bacchus I, Sathiaseelan V, Mittal B . Thyroid V50 Highly Predictive of Hypothyroidism in Head-and-Neck Cancer Patients Treated With Intensity-modulated Radiotherapy (IMRT). Am J Clin Oncol. 2014; 40(4):413-417. DOI: 10.1097/COC.0000000000000165. View

20.

Diaz R, Jaboin J, Morales-Paliza M, Koehler E, Phillips J, Stinson S . Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009; 77(2):468-76. DOI: 10.1016/j.ijrobp.2009.05.018. View